- Home
- STEM vs IMRX Comparison
STEM vs IMRX Comparison
Compare STEM & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEM
- IMRX
- Stock Information
- Founded
- STEM 2009
- IMRX 2008
- Country
- STEM United States
- IMRX United States
- Employees
- STEM N/A
- IMRX N/A
- Industry
- STEM Computer Software: Prepackaged Software
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- STEM Technology
- IMRX Health Care
- Exchange
- STEM Nasdaq
- IMRX Nasdaq
- Market Cap
- STEM 55.1M
- IMRX 62.7M
- IPO Year
- STEM N/A
- IMRX 2021
- Fundamental
- Price
- STEM $0.37
- IMRX $1.27
- Analyst Decision
- STEM Hold
- IMRX Strong Buy
- Analyst Count
- STEM 9
- IMRX 2
- Target Price
- STEM $1.17
- IMRX $12.50
- AVG Volume (30 Days)
- STEM 3.1M
- IMRX 170.4K
- Earning Date
- STEM 04-29-2025
- IMRX 05-06-2025
- Dividend Yield
- STEM N/A
- IMRX N/A
- EPS Growth
- STEM N/A
- IMRX N/A
- EPS
- STEM N/A
- IMRX N/A
- Revenue
- STEM $144,584,000.00
- IMRX N/A
- Revenue This Year
- STEM $57.72
- IMRX N/A
- Revenue Next Year
- STEM $21.95
- IMRX N/A
- P/E Ratio
- STEM N/A
- IMRX N/A
- Revenue Growth
- STEM N/A
- IMRX N/A
- 52 Week Low
- STEM $0.29
- IMRX $1.00
- 52 Week High
- STEM $1.97
- IMRX $3.83
- Technical
- Relative Strength Index (RSI)
- STEM 49.14
- IMRX 34.48
- Support Level
- STEM $0.29
- IMRX $1.23
- Resistance Level
- STEM $0.39
- IMRX $1.38
- Average True Range (ATR)
- STEM 0.04
- IMRX 0.11
- MACD
- STEM 0.00
- IMRX -0.01
- Stochastic Oscillator
- STEM 66.94
- IMRX 26.42
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.